Streetbeat News

GNMLF

Genomma Lab Internacional SAB

Industry

Medicinal and Botanical Manufacturing

Open

1.13

Mkt cap

1.3B

Volume

100

High

1.27

P/E Ratio

21.25

52-wk high

1.27

Low

1.13

Div yield

0.62

52-wk low

0.79

Procaps Group has entered into a strategic agreement with Genomma Lab Internacional, S.A.B. de C.V. to manufacture and market softgel products in Latin America. This partnership leverages Procaps' expertise in oral delivery system technology and manufacturing capabilities with Genomma's strategic marketing and distribution network in the region.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 8:08 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.